FDA Warning Letter — CBI Laboratories, Inc.
The FDA took a Warning Letter action against CBI Laboratories, Inc. on Oct 9, 2018 (Fort Worth, TX). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- CBI Laboratories, Inc.
- Date
- Oct 9, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Fort Worth, TX (United States)